(CNCN) Helix BioPharma Corp. Announces the Receipt of Subscription … – Wall Street Journal
(CNCN) Helix BioPharma Corp. Announces the Receipt of Subscription …Wall Street Journal(TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has received private placement subscription agreements for common shares and warrants for … and more …read more